Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis

References

• Chapman RW, Arborgh BM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 1870–7
   Web of Science ®Google Scholar
• Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 patients with primary sclerosing cholangitis. Gut 1996; 38: 610–5
   PubMed Web of Science ®Google Scholar
• Björnsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002; 51: 731–5
   PubMed Web of Science ®Google Scholar
• Donaldsson PT. Immunogenetics and epidemiology of primary sclerosing cholangitis. Primary sclerosing cholangitis, M Manns, RW Chapman, A Stiehl, R Wiesner. Kluwer Academic Publishers, London 1998; 22–36
   Google Scholar
• Vierling J. Aetiopathogenesis of primary sclerosing cholangitis. Primary sclerosing cholangitis, M Manns, RW Chapman, A Stiehl, R Wiesner. Kluwer Academic Publishers, London 1998; 22–36
   Google Scholar
• Chapman RW. Primary sclerosing cholangitis as an autoimmune disease: pros and cons. Immunology and liver, MP Manns, G Paumgartner, U Leuschner. Kluwer Academic Publishers, London 2000; 279–87
   Google Scholar
• Björnsson, E, Chapman, R. Primary sclerosing cholangitis, . In: M Trauner, Jansen, PLM, editors. Molecular pathogenesis of cholestasis. Landes Bioscience. ©2002 Eurekah.com. Available at:, http://www. eurekah.com.
   Google Scholar
• Kono K, Ohnishi K, Omata M, Saito M, Nakayama T, Hatano H, et al. Experimental portal fibrosis produced by intraportal injection of killed non-pathogenic Escherichia coli in rabbits. Gastroenterology 1988; 94: 787–96
   PubMed Web of Science ®Google Scholar
• Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB. Degradation of endogeneous bacterial cell wall polymers by the muralytic enzyme mutanalysis prevents hepatobiliary injury in the genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest 1992; 90: 1313–22
   PubMed Web of Science ®Google Scholar
• Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS, Broom MF. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology 1988; 94: 1006–13
   PubMed Web of Science ®Google Scholar
• Palmer KR, Duerden BI, Holdsworth CD. Bacteriological and endotoxin studies of severe cases of ulcerative colitis submitted to surgery. Gut 1980; 21: 851–4
   PubMed Web of Science ®Google Scholar
• Eade MN, Brooke BN. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet 1969; i: 1008–9
   Google Scholar
• Perret AD, Higgins G, Johnston HH, Massarella GR, Truelove SC, Wright R. The liver in ulcerative colitis. Q J Med 1971; 40: 211–38
   PubMedGoogle Scholar
• Dew MJ, Thompson H, Allan RJ. The spectrum of hepatic dysfunction in inflammatory bowel disease. Q J Med 1979; 48: 113–35
   PubMedGoogle Scholar
• Olsson R, Björnsson E, Bäckman L, Frimann S, Höckerstedt K, Kajser B, et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998; 28: 426–32
   PubMed Web of Science ®Google Scholar
• Budillon G, Parrilli G, Pacella M, Cuomo R, Menzies IS. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1985; 1: 513–24
   PubMed Web of Science ®Google Scholar
• Resnick RH, Royal H, Marshall W, Barron R, Werth T. Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA. Dig Dis Sci 1990; 35: 205–11
   PubMed Web of Science ®Google Scholar
• Romiti A, Merli M, Martorano M, Parrilli G, Martino F, Riggio, et al. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol 1990; 22: 118–23
   PubMedGoogle Scholar
• Bac JD, Swart GR, van den Berg JW, Wilson JP. Small bowel wall function with advanced cirrhosis and portal hypertension: studies on permeability and luminal bacterial overgrowth. Eur J Gastroenterol Hepatol 1993; 5: 383–7
   Web of Science ®Google Scholar
• Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11: 755–9
   PubMed Web of Science ®Google Scholar
• Ersoz G, Aydin A, Erdem S, Yuksel D, Akarca U, Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 409–12
   PubMed Web of Science ®Google Scholar
• Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000; 32: 742–7
   PubMed Web of Science ®Google Scholar
• Huglo D, De Botton S, Canva-Delcambre V, Colombel JF, Wallaert B, Steinling M, et al. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med 2001; 28: 1505–11
   PubMedGoogle Scholar
• Fujii T, Seki T, Maruoka M, Tanaka J, Kawashima Y, Watanabe T, et al. Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis. Hepatol Res 2001; 19: 158–69
   PubMed Web of Science ®Google Scholar
• Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50: 1482–6
   PubMed Web of Science ®Google Scholar
• Zuckerman MJ, Menzies IS, Ho H, Gregory GG, Casner NA, Crane RS, et al. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 2004; 49: 621–6
   PubMed Web of Science ®Google Scholar
• Di Leo V, Venturi C, Baragiotta A, Martines D, Floreani A. Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2003; 15: 967–73
   PubMed Web of Science ®Google Scholar
• Stotzer PO, Björnsson ES, Abrahamsson H. Interdigestive and postprandial motility in small intestinal bacterial overgrowth. Scand J Gastroenterol 1996; 31: 875–80
   PubMed Web of Science ®Google Scholar
• Saltzman JR, Kowdley KV, Pedrosa MC, Sepe T, Golner B, Perrone G, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994; 106: 615–23
   PubMed Web of Science ®Google Scholar
• Stotzer PO, Brandberg A, Kilander A. Diagnosis of small intestinal bacterial overgrowth in clinical praxis: a comparison of the culture of small bowel aspirate, duodenal biopsies and gastric aspirate. Hepatogastroenterology 1998; 45: 1018–22
   PubMedGoogle Scholar
• Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, Banan A. Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 784: 145–54
   PubMed Web of Science ®Google Scholar
• Menzies IS, Mount JN, Wheeler MJ. Quantitative estimation of clinically important monosaccharides in plasma by rapid thin layer chromatography. Ann Clin Biochem 1978; 15: 65–76
   PubMed Web of Science ®Google Scholar
• Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE. Intestinal permeability and function in patients infected with human immunodeficiency virus. Scand J Gastroenterol 1993; 28: 573–80
   PubMed Web of Science ®Google Scholar
• Armbrecht U, Bosaeus I, Gillberg R, Seeberg S, Stockbruegger R. Hydrogen (H2) breath test and gastric bacteria in acid-secreting subjects and in achlorhydric and postgastrectomy patients before and after antimicrobial treatment. Scand J Gastroenterol 1985; 20: 805–1366
   PubMed Web of Science ®Google Scholar
• Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566–81
   PubMed Web of Science ®Google Scholar
• Menzies, IS. Transmucosal passage of inert molecules in health and disease. In: Intestinal absorption and secretion. E Skadhauge, Heintze, K, editors. Falk Symposium 36. Lancaster: MTP Press; 1984. pp, 527–443.
   Google Scholar
• Misra V, Misra SP, Dwivedi M, Gupta SC. Histomorphometric study of portal hypertensive enteropathy. Am J Clin Pathol 1997; 108: 652–7
   PubMed Web of Science ®Google Scholar
• Such J, Guardiola JV, de Juan J, Casellas JA, Pascual S, Aparicio JR, et al. Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol 2002; 14: 371–6
   PubMed Web of Science ®Google Scholar
• Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestinal dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 1187–90
   PubMed Web of Science ®Google Scholar
• Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C. Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth and liver function. Am J Gastroenterol 2001; 96: 1251–5
   PubMed Web of Science ®Google Scholar
• Bauer T, Schawacha H, Steinbrückner B, Brinkmann FE, Ditzen AK, et al. Diagnosis of small intestinal overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 2000; 33: 382–6
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir SA, Sadik R, Shev S, Simrén M, Sjövall H, Stotzer P-O, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003; 98: 1362–70
   PubMed Web of Science ®Google Scholar
• Björnsson E, Kilander A, Olsson R. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis: a study of bile cultures from ERCP. Hepatogastroenterology 2000; 47: 1504–8
   PubMed Web of Science ®Google Scholar